The U.S. health regulator on January 13 approved Zoetis Inc,’s once-a-month injection to treat pain in cats with osteoarthritis, a common but difficult-to-diagnose condition that affects the joints in older cats.
If you are not happy with the results below please do another search
50 search results for:
Scorpion Therapeutics and AstraZeneca partnered to develop precision medicines against previously hard-to-target cancer proteins.
Since acquiring Allergan for $63 billion in 2019, AbbVie said it’s “tracking well” against the financial commitment the company made when striking the deal. Chief Financial Officer Rob Michael said at the 2022 J.P. Morgan Healthcare Conference the company is exceeding AbbVie’s revenue expectations in the aesthetics market, led by Botox.
Prellis Biologics entered into a multi-target drug discovery collaboration and licensing agreement with Bristol Myers Squibb utilizing the Bay Area biotechnology company’s first-in-class externalized human immune system (EXIS) based on human lymph node organoids (LNO).
Evoke announced three key leadership hires to the global health and wellness agency’s executive team.
imre named Anna Kotis as the new president of imre Health, as the digital powerhouse continues to elevate its life sciences offerings and catalyze year-over-year growth into more robust digital AOR engagements.
President Joe Biden on January 13 said he will deploy more military health workers to six U.S. states beginning next week, and give Americans free masks and more free tests to tackle the fast-spreading Omicron variant around the country.
Poorer nations during December 2021 rejected more than 100 million doses of COVID-19 vaccines distributed by the global program COVAX, mainly due to their rapid expiration date, a UNICEF official said on January 13.
A record 14.1 million Americans signed up for health insurance since the start of the 2022 open enrollment period in November 2021, the U.S. health department said on January 13.
NRx Pharmaceuticals filed a counter lawsuit against Relief Therapeutics, the company it initially partnered with to develop the experimental COVID-19 treatment aviptadil, which was submitted to the U.S. Food and Drug Administration for Emergency Use Authorization.